TNFRSF9 and non-small cell lung carcinoma: The patient with NSCLC who achieved PR had the highest CD8/FoxP3 ratio and proportion of 4-1BB/CD137+ cells in the IM, coupled with the lowest CD8/FoxP3 ratio throughout the tumor itself.